These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31720370)

  • 21. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.
    Campo A; Mathai SC; Le Pavec J; Zaiman AL; Hummers LK; Boyce D; Housten T; Champion HC; Lechtzin N; Wigley FM; Girgis RE; Hassoun PM
    Am J Respir Crit Care Med; 2010 Jul; 182(2):252-60. PubMed ID: 20339143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
    Bergot E; Sitbon O; Cottin V; Prévot G; Canuet M; Bourdin A; de Groote P; Rottat L; Gressin V; Jaïs X; Humbert M; Simonneau G
    Int J Cardiol; 2014 Apr; 172(3):561-7. PubMed ID: 24529947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension.
    Jing ZC; Xu XQ; Han ZY; Wu Y; Deng KW; Wang H; Wang ZW; Cheng XS; Xu B; Hu SS; Hui RT; Yang YJ
    Chest; 2007 Aug; 132(2):373-9. PubMed ID: 17400671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.
    Chung L; Farber HW; Benza R; Miller DP; Parsons L; Hassoun PM; McGoon M; Nicolls MR; Zamanian RT
    Chest; 2014 Dec; 146(6):1494-1504. PubMed ID: 24992469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of Left-to-Right Shunt Repair in Children with Pulmonary Arterial Hypertension at a Tertiary Hospital in a Low-to-Middle-Income Country.
    Arafuri N; Murni IK; Idris NS; Uiterwaal CSPM; Savitri AI; Nugroho S; Noormanto N
    Glob Heart; 2021 Apr; 16(1):25. PubMed ID: 34040938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical characteristics and long-term prognosis of pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.
    Li W; Xiong CM; Gu Q; Wang XT; Cheng XL; Huang L; Yang T; Luo Q; Zhao ZH; Ni XH; Liu ZH; He JG
    Pulm Circ; 2018; 8(2):2045894018759918. PubMed ID: 29480092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
    Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right atrial pressure/pulmonary artery wedge pressure ratio: A more specific predictor of survival in pulmonary arterial hypertension.
    Fares WH; Bellumkonda L; Tonelli AR; Carson SS; Hassoun PM; Trow TK; Herzog EL; Kaminski N; Kholdani CA; Zhang L; Zhou Y; Hammel JP; Dweik RA
    J Heart Lung Transplant; 2016 Jun; 35(6):760-7. PubMed ID: 26856665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
    Xie F; Quan R; Zhang G; Tian H; Chen Y; Yu Z; Zhang C; Liu Y; Zhu X; Wu W; Zhu X; Yang Z; Gu Q; Xiong C; Han H; Cheng Y; He J; Wu Y
    J Heart Lung Transplant; 2023 Jul; 42(7):974-984. PubMed ID: 37002152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.
    Ratwatte S; Anderson J; Strange G; Corrigan C; Collins N; Celermajer DS; Dwyer N; Feenstra J; Keating D; Kotlyar E; Lavender M; Whitford H; Whyte K; Williams T; Wrobel JP; Keogh A; Lau EM;
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes long term prognosis of 17 patients with pulmonary artery hypertension].
    Enríquez A; Castro P; Sepúlveda P; Verdejo H; Greig D; Gabrielli L; Ferrada M; Lapostol C
    Rev Med Chil; 2011 Mar; 139(3):327-33. PubMed ID: 21879164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases.
    Alves JL; Gavilanes F; Jardim C; Fernandes CJCDS; Morinaga LTK; Dias B; Hoette S; Humbert M; Souza R
    Chest; 2015 Feb; 147(2):495-501. PubMed ID: 25317567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension.
    Sulica R; Sangli S; Chakravarti A; Steiger D
    Pulm Circ; 2019; 9(1):2045894019826944. PubMed ID: 30638432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
    Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
    JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic performance of pulmonary effective arterial elastance in patients with heart failure].
    Wu YH; Huang BP; Feng JY; Huang LY; Zhao XM; Wang J; Guan JY; Li XQ; Zhang YH; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Apr; 52(4):397-404. PubMed ID: 38644255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.